Richard P. Bryce - 30 Nov 2023 Form 4 Insider Report for enGene Holdings Inc. (ENGN)

Role
Chief Medical Officer
Signature
/s/ Richard P. Bryce
Issuer symbol
ENGN
Transactions as of
30 Nov 2023
Net transactions value
$0
Form type
4
Filing time
04 Dec 2023, 17:55:37 UTC
Previous filing
31 Oct 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENGN Stock Option (Right to Buy) Award $0 +153,000 $0.000000 153,000 30 Nov 2023 Common Shares 153,000 $7.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests at 25% on the first anniversary of the grant date, with the remaining portion to vest monthly over the remaining three years.